Selected HighlightsFirst quarter net loss of $3.4 millionQuarterly Operating EBITDA* of $57.0 millionCash on hand and available credit facilities provide […]
BURLINGTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its first-quarter […]